Krystal Biotech, Inc.
KRYS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $4,479,223 | $3,368,749 | $2,019,454 | $1,552,669 |
| - Cash | $344,865 | $358,328 | $161,900 | $341,246 |
| + Debt | $7,261 | $8,094 | $8,933 | $8,024 |
| Enterprise Value | $4,141,619 | $3,018,515 | $1,866,487 | $1,219,447 |
| Revenue | $290,515 | $50,699 | $0 | $0 |
| % Growth | 473% | – | – | – |
| Gross Profit | $270,454 | $47,605 | $0 | $0 |
| % Margin | 93.1% | 93.9% | – | – |
| EBITDA | $109,909 | -$91,316 | -$116,811 | -$66,229 |
| % Margin | 37.8% | -180.1% | – | – |
| Net Income | $89,159 | $10,932 | -$139,975 | -$69,570 |
| % Margin | 30.7% | 21.6% | – | – |
| EPS Diluted | 3 | 0.39 | -5.49 | -3.13 |
| % Growth | 669.2% | 107.1% | -75.4% | – |
| Operating Cash Flow | $123,420 | -$88,804 | -$100,569 | -$47,938 |
| Capital Expenditures | -$4,238 | -$11,799 | -$52,979 | -$68,336 |
| Free Cash Flow | $119,182 | -$100,603 | -$153,548 | -$116,274 |